These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9756397)

  • 1. Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: role of 5-HT(2C) receptors.
    Grignaschi G; Invernizzi RW; Fanelli E; Fracasso C; Caccia S; Samanin R
    Br J Pharmacol; 1998 Aug; 124(8):1781-7. PubMed ID: 9756397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor.
    Hjorth S; Westlin D; Bengtsson HJ
    Neuropharmacology; 1997; 36(4-5):461-5. PubMed ID: 9225270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo.
    Hjorth S; Bengtsson HJ; Milano S
    Eur J Pharmacol; 1996 Nov; 316(1):43-7. PubMed ID: 8982649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT(1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing.
    Arborelius L; Wallsten C; Ahlenius S; Svensson TH
    Eur J Pharmacol; 1999 Oct; 382(2):133-8. PubMed ID: 10528148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalepsy induced by the 5-HT(1A) receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram.
    Eltayb A; Svensson TH; Ahlenius S
    Eur J Pharmacol; 2001 Jan; 411(3):275-7. PubMed ID: 11164384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo.
    Arborelius L; Linnér L; Wallsten C; Ahlenius S; Svensson TH
    Psychopharmacology (Berl); 2000 Jul; 151(1):77-84. PubMed ID: 10958120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
    Romero L; Artigas F
    J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
    Stenfors C; Yu H; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):222-32. PubMed ID: 11218075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT2C receptors inhibit and 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy.
    Jakus R; Graf M; Juhasz G; Gerber K; Levay G; Halasz P; Bagdy G
    Exp Neurol; 2003 Dec; 184(2):964-72. PubMed ID: 14769389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
    Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
    Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters.
    Bandoh T; Hayashi M; Ino K; Takada S; Ushizawa D; Hoshi K
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):471-8. PubMed ID: 15589386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine(1A) receptor-mediated feedback: a microdialysis study in the amygdala.
    Bosker FJ; Cremers TI; Jongsma ME; Westerink BH; Wikström HV; den Boer JA
    J Neurochem; 2001 Mar; 76(6):1645-53. PubMed ID: 11259482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
    Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
    PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prelimbic cortex 5-HT1A and 5-HT2C receptors are involved in the hypophagic effects caused by fluoxetine in fasted rats.
    Stanquini LA; Resstel LB; Corrêa FM; Joca SR; Scopinho AA
    Pharmacol Biochem Behav; 2015 Sep; 136():31-8. PubMed ID: 26143050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram.
    Arborelius L; Nomikos GG; Grillner P; Hertel P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):157-65. PubMed ID: 7477438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of 5-HT(1A) receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model.
    Cervo L; Mocaër E; Bertaglia A; Samanin R
    Neuropharmacology; 2000 Apr; 39(6):1037-43. PubMed ID: 10727714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats.
    Grignaschi G; Fanelli E; Scagnol I; Samanin R
    Br J Pharmacol; 1999 Jul; 127(5):1190-4. PubMed ID: 10455265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.
    Invernizzi R; Velasco C; Bramante M; Longo A; Samanin R
    Neuropharmacology; 1997; 36(4-5):467-73. PubMed ID: 9225271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.